Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-18-000009

Options or other derivatives

  • Exec. Vice Chairman/CEO/Pres. acquired 250,000 shares (grant or award)
  • Exec. Vice Chairman/CEO/Pres. acquired 300,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

EQUELS THOMAS K. · Exec. Vice Chairman/CEO/Pres.

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-05-16 Grant or award : show line 1 in the form Options to buy Common Stock +250,000 250,000 D
2018-05-16 Other acquisition : show line 2 in the form Options to buy Common Stock +300,000 795,833 D
Loading xslF345X03/primary_doc.xml…